Elastosis Perforans Serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream.


Submitted: 12 August 2010
Accepted: 8 October 2010
Published: 29 October 2010
Abstract Views: 3381
PDF: 565
HTML: 2892
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Elastosis Perforans Serpiginosa (EPS) is a rare skin disease characterised by hyperkeratotic papules, transepidermal elimination of abnormal elastic fibres, and focal dermal elastosis. The aetiology is unknown, but an association with underlying systemic disorders, including Down syndrome has been describ­ed. Treatment is often difficult. A 45-year old man with Down syndrome presented with symmetrical annular elements on forearms and femora. The elements were erythematous with atrophic hypopigmented central healing and peripherally, infiltrated keratotic papules with desquamation. A punch biopsy showed the classical histopathologic features of EPS. We found no clinical signs of cerebrovascular or cardiovascular disease. We initiated topical therapy with imiquimod 5% cream once a day for 6 weeks followed by 3 times weekly for 4 weeks to a single element. As regression of EPS was observed and the patient tolerated the therapy well, treatment of other lesions was commenced, and further regression was seen.

Supporting Agencies


Gregersen, P. A., Stausbøl-Grøn, B., Ramsing, M., & Sommerlund, M. (2010). Elastosis Perforans Serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream. Dermatology Reports, 2(2), e15. https://doi.org/10.4081/dr.2010.e15

Downloads

Download data is not yet available.

Citations